Cost-effectiveness of implantable cardioverter-defibrillators.
Explore this paper's citation graph
Summary
Prophylactic implantation of an ICD has a cost-effectiveness ratio below 100,000 dollars per QALY gained in populations in which a significant device-related reduction in mortality has been demonstrated.
- Type
- article
- Published
- 2005-10-06
- Cited by
- 343
- References
- 36
- Access
- Open access
- OpenAlex
- https://openalex.org/W2000325901
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20136883
Keywords
Medicine, Defibrillation, Myocardial infarction, Clinical trial, Sudden cardiac death
References
- Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators. Myocardial Infarction Triage and Intervention.
- Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.
- Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
- Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction
- The Beaver Dam Health Outcomes study
- Quality of life in the Canadian Implantable Defibrillator Study (CIDS).
- PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION
- Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy.
- Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
- Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators.
- Automatic implantable cardioverter-defibrillator: patient survival, battery longevity and shock delivery analysis.
- Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction
- Medicare coverage of ICDs.
- Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.
- Cost-effectiveness of routine coronary angiography after acute myocardial infarction.
- Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
- Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
- Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death
- Preferences for quality of life or survival expressed by patients with heart failure.
- Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
Cited by
- Data Uncertainty in Markov Chains: Application to Cost-Effectiveness Analyses of Medical Innovations
- How to evaluate whether a new technology in the operating room is cost-effective from society's viewpoint.
- Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
- Sudden cardiac death in chronic kidney disease: epidemiology and prevention
- Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II).
- Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities
- Sudden cardiac death and implantable cardioverter-defibrillators.
- Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost?
- ESTUDO DE MÉTODOS DE AVALIAÇÃO DE TECNOLOGIAS EM SAÚDE APLICADA A EQUIPAMENTOS ELETROMÉDICOS
- Risk stratification in patients with heart failure and in patients with implantable cardioverter-defibrillators
- Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy.
- III Diretriz Brasileira de Insuficiência Cardíaca Crônica
- Estratificación del riesgo de muerte súbita en pacientes con corazones estructuralmente sanos
- Terapia eléctrica en la insuficiencia cardíaca
- Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study
- The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
- Modeling Outcome of Implantable Defibrillator Patients
- Primary prevention defibrillators in clinical practice
- A Review of Economic Factors Related to the Delivery of Health Care for Chronic Low Back Pain
- Approach to economic evaluation in primary care: review of a useful tool for primary care reform.
Related papers
- Effect of epinephrine on defibrillation in ischemic ventricular fibrillation.
- Precountershock cardiopulmonary resuscitation improves initial response to defibrillation from prolonged ventricular fibrillation: A randomized, controlled swine study*
- A prospective, randomized evaluation of effect of ventricular fibrillation duration on defibrillation thresholds in humans.
- 209 Evaluation of acute cardiac damage in a porcine model of defibrillation
- Validation of spectral energy for the quantitative analysis of ventricular fibrillation waveform to guide defibrillation in a porcine model of cardiac arrest and resuscitation.
- The impact of double sequential external defibrillation on termination of refractory ventricular fibrillation during out-of-hospital cardiac arrest.
- Waveform analysis of ventricular fibrillation to predict defibrillation
- Double sequential defibrillation for refractory ventricular fibrillation
- Delaying shock for cardiopulmonary resuscitation: does it save lives?